DurgicalDurgical
EN
Open the app

Cimetidine !

The first H2 blocker. It lowers stomach acid but inhibits liver enzymes and has antiandrogen effects, so it causes more interactions than famotidine.

Updated 2026-11-01

No structure of cimetidine in the H2 receptor exists; the figure shows famotidine, another H2 blocker, in the same histamine pocket of the human receptor.

Target in 3D: Histamine H2 receptor. PDB structure 7UL3 (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Cimetidine competes with histamine at the H2 receptor of the parietal cell and lowers basal, nocturnal and food-stimulated acid secretion. Separately, its imidazole ring binds cytochrome P450 enzymes in the liver and slows the metabolism of many drugs. It also blocks androgen receptors weakly, which explains gynaecomastia with prolonged use, and competes with creatinine for tubular secretion.

  1. Cimetidine blocks histamine at the parietal cell's H2 receptor
  2. Less cAMP signal: basal and nocturnal acid fall
  3. Its imidazole ring also inhibits liver CYP enzymes
  4. Other drugs build up; weak antiandrogen effects appear

Pharmacokinetics

Absorption
Rapidly absorbed by mouth; peak levels in 45–90 minutes.
Metabolism
Partly in the liver; the sulfoxide is the main metabolite.
Elimination
Mainly in the urine, about half as unchanged drug.
Half-life
About 2 hours.

Indications

Adverse effects

Common

  • Headache, dizziness and drowsiness
  • Diarrhoea
  • Small rise in serum creatinine without real kidney damage
  • Gynaecomastia with prolonged use

Contraindications

  • Hypersensitivity to cimetidine

Key interactions

Warfarin
Slower warfarin metabolism; the INR (prothrombin time) rises and is monitored closely.
Phenytoin, theophylline and lidocaine
Higher levels with clinical toxicity reported.
Propranolol, nifedipine, diazepam, chlordiazepoxide, tricyclic antidepressants, metronidazole
Slower elimination and higher blood levels.
Ketoconazole and other acid-dependent drugs
Less absorption when gastric pH rises.
Antacids taken at the same time
They may reduce cimetidine absorption; the label does not recommend giving them together.

What is monitored

  • INR in patients on warfarin, and levels of phenytoin or theophylline
  • Mental status in older adults and in liver or kidney disease
  • Breast changes or sexual problems with long courses

Administration and safety

  • IV doses are not given as a rapid bolus, which has caused arrhythmias and hypotension
  • Separated in time from antacids
  • A response to treatment does not rule out gastric cancer

Nursing care

  • Review the medication list for warfarin, phenytoin, theophylline and other drugs with a narrow margin
  • Watch for confusion in older or very ill patients
  • Explain that a slight rise in creatinine can be due to the drug and not to kidney damage
  • Teach the patient to report breast swelling or tenderness

Pregnancy and breastfeeding

Animal studies showed no harm and there are no well-controlled studies in women; it is used in pregnancy only if clearly needed.

Test yourself

Think of the answer, then tap the question to see it.

Which feature of cimetidine's structure explains its many drug interactions?

Its imidazole ring binds and inhibits hepatic cytochrome P450 enzymes.

A man on long-term cimetidine for Zollinger–Ellison syndrome develops breast enlargement. What is the cause?

Cimetidine's weak antiandrogen effect.

Why can cimetidine raise serum creatinine without damaging the kidney?

It competes with creatinine for tubular secretion in the kidney.

Add to my cards (3)

← Back to the class: H2 receptor antagonists (H2 blockers)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - CIMETIDINE tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026); Medications for the Treatment of Gastric Acidity - Gastroenterology - MSD Manual Professional Edition (MSD Manual Professional Edition, 2025); Cimetidine: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.